Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.47 -0.15%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.30), versus ($0.20) reported last year. Revenue for the quarter came in at $1 thousand, versus $53 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royalty Pharma plc (RPRX) 2K contracts of August 60 calls trade
- Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
